YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

PML

Biotech firms' drug is linked to deaths

Dec 19, 2006 | Los Angeles Times
The bestselling medicine for two of the country's biggest biotech drug companies has been further linked to a rare and deadly brain infection, U.S....

Biogen, Genentech issue warning for Rituxan

Dec 19, 2006 | www.cbsmarketwatch.com
Biogen Idec and Genentech have issued a warning to healthcare providers for their oncology drug Rituxan, advising them that the drug has been linked...

Rituxan (rituxamab) Linked to Two Deaths in Lupus Patients

Dec 19, 2006 | www.medpagetodaycom
Two patients treated with the immune modulator Rituxan (rituximab) for systemic lupus erythmatosus (SLE) have died of progressive multifocal...

Off-Label Use of Rituxan Linked to Fatal Leukoencephalopathy

Dec 19, 2006 | www.medscape.com
The US Food and Drug Administration (FDA) is warning healthcare professionals regarding the risk for progressive multifocal leukoencephalopathy (PML)...

Rituxan warning issued by FDA

Dec 19, 2006 | North County Times
Patients treated with Rituxan may be at risk from a rare, fatal brain infection, the U.S. Food and Drug Administration warned Monday. The FDA said...

FDA ALERT

Dec 18, 2006 | www.fda.gov
This Alert highlights important emerging safety information about Rituxan. Two patients have died after being treated with Rituxan for systemic lupus...

Life-threatening Brain Infection in Patients with Systemic Lupus Erythematosus

Dec 18, 2006 | www.fda.gov
FDA has received reports of the death of two patients who were treated with Rituxan for systemic lupus erythematosus (SLE).  Both patients...

FDA issues alert on Genentech drug

Dec 18, 2006 | AP
Government health officials said Monday they are seeking additional safety information from Genentech Inc. on Rituxan following reports that two...

Rituxan (Rituximab) - Life-Threatening Brain Infection

Dec 18, 2006 | www.fda.gov
FDA and Genentech informed healthcare professionals of important emerging safety information about Rituxan. Two patients died after being treated...

FDA Warns of Severe Side Effects Associated with Rituxan

Dec 18, 2006 | NewsInferno.com
In an alert issued today, the U.S. Food and Drug Administration connected Rituxan with a fatal viral infection of the central nervous system....

Page 1/2 [first] [prev] 1 2 [next] [last]

Progressive Multifocal Leukoencephalopathy
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

If you believe PML is due to an Multiple Sclerosis drug, please list drug:

Please describe your case:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | ReNu with MoistureLoc | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2008 YourLawyer.com. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News